EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 8 May 2025

New data shows no shift in access to medicines for millions of Europeans

Learn more here.

New data from two reports, published on 7 May by EFPIA, highlight the ongoing challenges of providing equal access to medicines for all Europeans.

Part of EFPIA’s ongoing commitment to build data on access and availability of medicines in Europe, the Patients W.A.I.T. Indicator shows persistent, significant variation in access to new medicines between countries across the EU, while the CRA Report on the Root Causes of Unavailability and Delay to Innovative Medicines identifies the numerous interlinked reasons behind the delays and barriers that patients face.

EFPIA’s recommendations for the future EU Multiannual Financial Framework
08 May 2025

The future MFF should support the life sciences research and innovation ecosystem, ensure the competitiveness of the... Read more

Events

MSCA Staff Exchanges hybrid information session
05 June 2025 (Alicante, Hybrid)

Join the hybrid information session on 5 June 2025 to learn more about MSCA Staff Exchanges. Read more

IHI Call Days - call 11
23 June 2025 (Virtual event)

The IHI Call Days for IHI call 11 will take place from 23 to 30 June 2025 online and will include sessions on the individual... Read more

Biotech Business Mission to Japan 2025 - Call for applications
06 October 2025 (Osaka & Yokohama, Japan)

Join the biotech business mission in Japan from 6-10 October 2025, organised by the EU-Japan Centre for Industrial Cooperation.... Read more

Trials@Home Closing Event 2025
31 October 2025 (Utrecht, Hybrid)

Join the conference on 31 October, dedicated to presenting the project’s recommendations on the conduct of DCTs, featuring... Read more

Join our team!

We have 4 job opportunities available:

Director, Public Affairs
Manager, Legal Affairs – Corporate Sustainability & Policy
Junior Manager, Public Affairs
Intern, Legal Affairs

To apply, please send your CV and cover letter to vacancy@efpia.eu.

You can find more details here.

What we are reading

What it takes to get the ERNs to the next level
On 05 May 2025 (Eurordis)

Rare diseases are, by nature, complex and often geographically scattered. No single country can hold all the expertise... Read more

Joint IFPMA – EFPIA – EUCOPE statement to support the adoption of the WHA Resolution on Rare...
On 05 May 2025 (IFPMA)

On 5 May 2025, IFPMA, EFPIA, and EUCOPE issued a statement supporting the World Health Assembly Resolution and Global... Read more

Can pharmacists accelerate HPV vaccine uptake and help eliminate cervical cancer?
On 01 May 2025 (Vaccines Today)

Pharmacists already deliver flu vaccines in several European countries. Now some are ready for a new challenge ‒... Read more

Health innovation critical to resilience and competitiveness, says Ireland’s EIT Health
On 30 April 2025 (Euractiv)

Global health resilience needs European innovation, says EIT Health, Ireland. Innovation is at the heart of a new... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu